health outcome

健康结果
  • 文章类型: Journal Article
    危重病人的用药方案复杂而动态,导致毒品相关问题的高发生率。这项研究旨在评估这些患者的药学服务的有效性和经济效率。
    在这项在三级医院进行的前瞻性队列研究中,根据现有的临床分组规则,将成年患者分为临床药学服务组或对照组.收集健康结果和经济指标,其次是成本效益分析。
    临床药师干预的接受率为89.31%。药物护理组显着降低了用药错误率(40.65%vs.61.69%,P<0.001)和药物不良事件(44.52%vs.56.45%,P=0.020)。特殊等级抗生素的使用率(85.16%vs.91.13%,P=0.009)和质子泵抑制剂(77.42%vs.88.71%,P=0.002)在药物护理组中也较低。次要结局在总住院时间上没有显着差异(21天与22天,P=0.092)。然而,ICU住院时间明显缩短(9天vs.11天,药物护理组的P=0.003)。成本-效果分析表明,与ICU药物护理相关的不良药物事件每减少1%,可节省ICU住院费用226.75美元,ICU药物总费用203.42美元。药物错误率降低1%,可节省ICU住院费用128.57美元,ICU总药费115.34美元。
    药学监护显著减少药物不良事件和用药错误,促进合理使用药物,缩短ICU住院时间,降低危重病人的治疗费用,在成本效益方面建立明确的优势。
    UNASSIGNED: The medication regimen for critically ill patients is complex and dynamic, leading to a high incidence of drug-related problems. This study aimed to assess the effectiveness and economic efficiency of pharmaceutical care for these patients.
    UNASSIGNED: In this prospective cohort study conducted in a tertiary hospital, adult patients were assigned either to a clinical pharmaceutical care group or a control group based on existing clinical grouping rules. Health outcomes and economic indicators were collected, followed by a cost-effectiveness analysis.
    UNASSIGNED: The acceptance rate for clinical pharmacist interventions was 89.31%. The pharmaceutical care group exhibited significant reductions in the rate of medication errors (40.65% vs. 61.69%, P < 0.001) and adverse drug events (44.52% vs. 56.45%, P = 0.020). The usage rates for special-grade antibiotics (85.16% vs. 91.13%, P = 0.009) and proton pump inhibitors (77.42% vs. 88.71%, P = 0.002) were also lower in the pharmaceutical care group. Secondary outcomes did not show significant differences in total hospital stay (21 days vs. 22 days, P = 0.092). However, ICU stay was significantly shorter (9 days vs. 11 days, P = 0.003) in the pharmaceutical care group. Cost-effectiveness analysis demonstrated that each 1% reduction in adverse drug events associated with ICU pharmaceutical care saved $226.75 in ICU hospitalization costs and $203.42 in total ICU drug costs. A 1% reduction in the medication error rate saved $128.57 in ICU hospitalization costs and $115.34 in total ICU drug costs.
    UNASSIGNED: Pharmaceutical care significantly reduces adverse drug events and medication errors, promotes rational use of medications, decreases the length of ICU stay, and lowers treatment costs in critically ill patients, establishing a definitive advantage in terms of cost-effectiveness.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Editorial
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    有越来越多的证据表明,衰老过程在生命的早期阶段开始,在子宫内,个体的环境起着重要的作用。因此,了解早年生活环境对老年健康的持久影响至关重要。
    在这项研究中,我们进行了一项荟萃分析,以研究中国饥荒(1959-1961)对老年人健康的影响.我们还探索了这些影响的潜在机制。
    早期生活环境之间复杂的相互作用,多个卫生相关部门,健康老龄化需要全面的生命历程方法和战略干预措施,以增强老龄化社会的公共卫生。
    UNASSIGNED: There is mounting evidence indicating that the aging process initiates during early life stages, with in utero the individual\'s environment playing a significant role. Consequently, it is crucial to comprehend the enduring effects of early life circumstances on health in old age.
    UNASSIGNED: In this study, we conducted a meta-analysis to examine the effects of the Chinese Famine (1959-1961) on the health of older adults. We also explored potential mechanisms underlying these effects.
    UNASSIGNED: The complex interplay between early life circumstances, multiple health-related sectors, and healthy aging necessitates a comprehensive life-course approach and strategic interventions to enhance public health in an aging society.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:包皮环切术作为世界范围内常见的择期儿科手术,对父母和孩子来说是一种压力和焦虑的经历。尽管目前的围手术期干预措施被证明是有效的,比如减少术前焦虑,使用移动应用程序的整体解决方案有限。
    目的:本文旨在描述智能客户驱动的基于智能手机的应用程序程序(ICory-Circumcision)的开发和初步评估,以改善接受包皮环切术的儿童及其家庭照顾者的健康结果。
    方法:在文献回顾和前人研究的基础上,采用班杜拉的自我效能理论作为概念框架。建立了一个多学科团队来识别内容并开发应用程序。进行了半结构化访谈以评估包皮环切术。
    结果:该研究于2019年3月至2020年1月进行,包括2个移动应用程序,BuddyCare应用程序和TriumfHealth手机游戏应用程序。前者为孩子接受包皮环切术的父母提供了日常的围手术期指南,而后者为孩子提供情感支持和分散注意力。总的来说,招募了6名参与者使用这些应用程序,并进行了访谈以评估该计划。总的来说,内容分析产生了4个主类别和10个子类别。
    结论:包皮环切术似乎倾向于有用。在进行随机对照试验之前,有必要对包皮环切术进行修订以增强其内容和特征。
    背景:ClinicalTrials.govNCT04174404;https://clinicaltrials.gov/ct2/show/NCT04174404。
    BACKGROUND: Circumcision as a common elective pediatric surgery worldwide is a stressful and anxiety-inducing experience for parents and children. Although current perioperative interventions proved effective, such as reducing preoperative anxiety, there are limited holistic solutions using mobile apps.
    OBJECTIVE: This paper aims to describe the development and primary evaluation of an intelligent customer-driven smartphone-based app program (ICory-Circumcision) to enhance health outcomes among children undergoing circumcision and their family caregivers.
    METHODS: Based on the review of the literature and previous studies, Bandura\'s self-efficacy theory was adopted as the conceptual framework. A multidisciplinary team was built to identify the content and develop the apps. Semistructured interviews were conducted to evaluate the ICory-Circumcision.
    RESULTS: The ICory-Circumcision study was carried out from March 2019 to January 2020 and comprised 2 mobile apps, BuddyCare app and Triumf Health mobile game app. The former provides a day-by-day perioperative guide for parents whose children are undergoing circumcision, while the latter provides emotional support and distraction to children. In total, 6 participants were recruited to use the apps and interviewed to evaluate the program. In total, 4 main categories and 10 subcategories were generated from content analysis.
    CONCLUSIONS: ICory-Circumcision seemed to lean toward being useful. Revisions to ICory-Circumcision are necessary to enhance its contents and features before advancing to the randomized controlled trial.
    BACKGROUND: ClinicalTrials.gov NCT04174404; https://clinicaltrials.gov/ct2/show/NCT04174404.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究旨在研究将患者报告的结果(PRO)整合到常规临床实践中对接受积极抗癌治疗的患者的潜在益处。
    我们对接受积极抗癌治疗的癌症患者的随机对照试验进行了全面的系统评价,跨越各种癌症类型和阶段。审查涵盖了四个电子数据库(Medline,EMBASE,科克伦图书馆,和CINAHL)截至2022年9月。关键的纳入标准侧重于将PRO纳入常规干预措施。偏差评估遵循Cochrane协作的标准,而结果的合成利用了效应大小测量(科恩的d)。该研究遵循系统评价和荟萃分析指南的首选报告项目。
    在最初筛选的1549条记录中,包含5300名患者的16项已发表的随机对照试验符合纳入标准。干预措施涉及18种不同的PRO测量,突出的工具是EORTCQLQ-C30(在四个试验中使用)和PRO-CTCAE(在四个试验中使用)。测量终点包括总体生活质量(12项试验),身体健康(11项试验),心理健康(7项试验),和社会健康(5项试验)。总的来说,这项研究揭示了有限数量的统计上显著的发现,与干预措施相关的效应大小主要是小到中等。
    研究结果表明,将PRO常规整合到临床实践中并不能在PRO方面产生明确的优势。显然,需要进一步努力来确定这些干预措施对患者健康的影响。
    审查方案已在PROSPERO上注册(ID:CRD4202236556)。
    UNASSIGNED: This study aims to investigate the potential benefits of integrating patient-reported outcomes (PROs) into routine clinical practice for patients undergoing active anticancer treatment.
    UNASSIGNED: We conducted a comprehensive systematic review of randomized controlled trials involving cancer patients undergoing active anticancer treatment, spanning various cancer types and stages. The review covered four electronic databases (Medline, EMBASE, Cochrane Library, and CINAHL) up to September 2022. Key inclusion criteria focused on the incorporation of PROs as a routine intervention. Bias assessment followed the Cochrane collaboration\'s criteria, while the synthesis of results utilized effect size measurements (Cohen\'s d). The study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
    UNASSIGNED: Out of 1549 initially screened records, 16 published randomized controlled trials encompassing 5300 patients met the inclusion criteria. The interventions involved 18 different PROs measurements, with prominent tools being EORTC QLQ-C30 (utilized in four trials) and PRO-CTCAE (utilized in four trials). Measured endpoints included overall quality of life (12 trials), physical health (11 trials), mental health (7 trials), and social health (5 trials). Overall, the study revealed a limited number of statistically significant findings, with predominantly small to moderate effect sizes associated with the interventions.
    UNASSIGNED: The findings suggest that the routine integration of PROs into clinical practice does not yield definitive advantages in terms of PROs. It is apparent that further efforts are necessary to ascertain the impact of these interventions on patient health.
    UNASSIGNED: The review protocol was registered on PROSPERO (ID: CRD42022365456).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    人乳(HM)与坏死性小肠结肠炎(NEC)的风险较低有关。然而,精确的HM比例与NEC结局的相关性尚不清楚.本研究共纳入77例病例和154个匹配的对照。根据NEC发病前肠内总摄入量的HM比例将样本分为三组:≥70%(HHM),<70%(LHM),0%(NHM)。研究队列未显示不同HM比例与NEC风险之间存在显著关联。最高与最低摄入量的调整后比值比(OR)为0.599。在NEC的预后中,不同的HM比例显著影响体重增加,NEC发作的时间,诊断时间,住院费用,和NEC的严重程度(p<0.05)。我们的发现支持HM对降低早产儿NEC的有益作用,特别是当它们的喂养中包括了总肠道摄入量中更大比例的HM时。此外,该研究表明,用较低比例的HM喂养的早产儿更容易经历严重的NEC病例。
    Human milk (HM) has been associated with a lower risk of necrotizing enterocolitis (NEC). However, the association of precise HM proportion with the outcome of NEC remains unclear. A total of 77 cases and 154 matched controls were included in this study. The samples were divided into three groups based on the HM proportion of the total enteral intake before NEC onset: ≥70% (HHM), <70% (LHM), and 0% (NHM). The study cohort did not show a significant association between different HM proportions and NEC risk. The adjusted odds ratio (OR) for the highest versus the lowest intake was 0.599. In the prognosis of NEC, different HM proportions significantly affected weight gain, the timing of NEC onset, diagnosis time, hospitalization cost, and the severity of NEC (p < 0.05). Our findings support the beneficial effects of HM on reducing NEC in preterm infants, particularly when a greater proportion of HM of the total enteral intake is included in their feeding. Additionally, the study indicates that preterm infants fed with lower proportions of HM of the total enteral feeding are more prone to experiencing severe cases of NEC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:性别差距仍然是实现平等的主要障碍,在低收入国家尤其广泛。寻求健康行为的性别差异可能是一个因素。家庭规模和分娩顺序是影响家庭资源配置的两个关键因素。这项研究调查了不同家庭结构(出生顺序和家庭规模)的中国农村视力障碍儿童寻求医疗保健行为的性别差异。
    方法:我们利用一个包含19,934个观测值的数据集,该数据集通过合并来自两个省的252个不同学校级别的调查数据而构建。这些调查都是在2012年使用统一的调查工具和数据收集协议在中国西部省份农村随机选择的学校进行的。样本儿童的等级从4到5。我们的分析比较了农村女孩和农村男孩的视力健康结果和行为(视力检查和矫正)。
    结果:研究结果表明,女孩的视力比男孩差。关于视力健康行为,女孩的总体视力检查率低于男孩。当样本学生是独生子女或家庭中最小的孩子时,没有性别差异,但是当样本学生是家庭中最大的孩子或出生顺序中的孩子时,仍然存在性别差异。当涉及到视力矫正行为时,对于轻度视力障碍的学生群体,男孩比女孩更有可能拥有眼镜,即使样本学生是家庭中唯一的孩子。然而,当样本学生有另一个兄弟或姐妹(样本学生是最小的,家里最大的孩子,或出生顺序中的中间孩子),性别差异消失。
    结论:农村儿童视力健康结果的性别差异与寻求视力健康行为的性别差异相关。根据出生顺序和家庭规模,视觉健康实践中的性别差异各不相同。在未来,应考虑提供医疗补贴,以降低视力健康行为的成本,并提供信息干预措施,以改变家庭中的性别不平等,促进儿童视力健康行为的平等。
    背景:该试验获得了斯坦福大学机构审查委员会的批准(方案编号:ISRCTN03252665).每个地区的地方教育委员会和所有学校的校长都获得了许可。始终遵循《赫尔辛基宣言》的原则。对于所有儿童参与者,从至少一位父母处获得书面知情同意书。
    The gender gap remains a major impediment in the path toward equality, and it is especially wide in low-income countries. Gender differences in health-seeking behaviors may be a factor. Family size and childbirth order are two critical factors affecting family resource allocation. This study examines gender differences in healthcare-seeking behaviors among children with visual impairment in rural China across different family structures (birth order and family size).
    We draw on a dataset containing 19,934 observations constructed by combining data from 252 different school-level surveys spanning two provinces. The surveys were all conducted in 2012 using uniform survey instruments and data collection protocols in randomly selected schools across western provinces in rural China. The sample children range in grades from 4 to 5. Our analysis compares rural girls with rural boys regarding vision health outcome and behavior (vision examination and correction).
    The findings revealed that girls have worse vision than boys. Regarding vision health behaviors, girls have a lower overall vision examination rate than boys. There is no gender difference when the sample student is the only child or the youngest child in the family, but there is still a gender difference when the sample student is the oldest child in the family or the middle child in the birth order. When it comes to vision correction behavior, boys are more likely to own eyeglasses than girls are for groups of students with mild visual impairment, even when the sample student is the only child in the family. However, when the sample student has another brother or sister (the sample student is the youngest, the oldest child in the family, or the middle child in the birth order), the gender difference disappears.
    Gender differences in vision health outcomes are correlated with gender differences in vision health-seeking behaviors among rural children. Depending on the birth order and family size, gender disparities in visual health practices vary. In the future, consideration should be given to providing medical subsidies to reduce the cost of vision health behaviors and to provide information interventions to change gender inequality in households and promote equality in children\'s vision health behaviors.
    The trial was approved by the Stanford University Institutional Review Board (Protocol No. ISRCTN03252665). Permission was received from local Boards of Education in each region and the principals of all schools. The principles of the Declaration of Helsinki were followed throughout. Written informed consent was obtained from at least one parent for all child participants.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    经济困难被描述为患者在癌症相关治疗后的经济经历。评估这种痛苦的标准化患者报告结局指标(PROM)尚未得到很好的研究,尤其是老年癌症幸存者。
    本研究的目的是开发和验证PROM,以评估中国老年癌症幸存者的经济困难。
    使用定性访谈和文献综述生成项目。根据Delphi专家咨询和患者意见筛选项目。使用项目反应理论(IRT)和经典测试理论(CTT)来帮助减少项目。保留的物品形成了经过心理测试的先导仪器。通过受试者工作特征(ROC)分析确定了用于预测不良生活质量的新仪器的截止分数。
    定性访谈和文献综述产生了135个项目,由于冗余,它们减少到60个项目。在德尔福专家咨询和患者评估之后,提取了24个具有高重要性的项目。由于基于CTT和IRT的统计分析令人满意,因此选择了16个项目。在探索性因子分析(EFA)中加载后,保留了10个项目,包含2个域。内部一致性令人满意(α=0.838)。重测可靠性良好(组内相关性,0.909)。ROC分析表明,18.5的截止值产生了可接受的灵敏度和特异性。
    困难与痛苦康复调查(HARDS)包括10个项目,这些项目特别反映了中国老年癌症幸存者的经济困难经历,在临床环境中也显示出良好的信度和效度。
    UNASSIGNED: Financial hardship has been described as a patient\'s economic experiencefollowing cancer-related treatment. Standardized patient-reported outcome measures(PROM) to assess this distress has not been well-studied, especially among older cancer survivors.
    UNASSIGNED: The aim of this study was to develop and validate PROM for assessing the financial hardship of older cancer survivors in China.
    UNASSIGNED: Items were generated using qualitative interviews and literature review. Items were screened based on Delphi expert consultation and patients\' opinions. Item response theory (IRT) and classical test theory (CTT) were used to help reduce items. Retained items formed a pilot instrument that was subjected to psychometric testing. A cut-off score for the new instrument for predicting poor quality of life was identified by receiver operating characteristic (ROC) analysis.
    UNASSIGNED: Qualitative interviews and literature review generated 135 items, which were reduced to 60 items because of redundancy. Following Delphi expert consultation and patients\' evaluation, 24 items with high importance were extracted. Sixteen items were selected due to satisfactory statistical analysis based on CTT and IRT. Ten items were retained and comprised 2 domains after loadings in exploratory factor analysis (EFA). Internal consistency was satisfactory (α = 0.838). Test-retest reliability was good (intraclass correlation, 0.909). The ROC analysis suggested that the cut-off of 18.5 yielded an acceptable sensitivity and specificity.
    UNASSIGNED: The PROM for Hardship and Recovery with Distress Survey (HARDS) consists of 10 items that specifically reflect the experiences of financial hardship among older Chinese cancer survivors, and it also showed good reliability and validity in clinical settings.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:多症对全球医疗保健系统造成了巨大负担,而多发病率的管理策略和指南尚不完善。我们的目标是综合目前关于多症干预和管理的证据。
    方法:我们搜索了四个电子数据库(PubMed,Embase,WebofScience,和Cochrane系统评价数据库)。纳入并评估了多重性疾病干预或管理的SRs。通过AMSTAR-2工具评估每个SR的方法学质量,通过建议评估的分级来评估干预措施有效性的证据质量,开发和评估(等级)系统。
    结果:共纳入30个SRs(464个独特的基础研究),包括20份干预措施和10份总结多症管理证据的SRs。确定了四类干预措施:患者级干预措施,提供者级别的干预措施,组织层面的干预,和联合干预措施(结合上述两个或三个层面的组成部分)。结果分为六种类型:身体状况/结果,精神状况/结果,社会心理结果/一般健康,医疗保健利用率和成本,患者的行为,和护理过程的结果。联合干预措施(包括患者级别和提供者级别的组成部分)在促进身体状况/结果方面更有效,而患者层面的干预措施在促进精神状况/结局和心理社会结局/一般健康方面更有效.至于医疗保健利用和护理过程结果,组织层面和联合干预措施(与组织层面的组成部分)更有效.患者多发病管理的挑战,还总结了提供者和组织级别。
    结论:不同级别的综合干预措施将有利于促进不同类型的健康结果。患者的管理存在挑战,提供者,和组织层面。因此,一种整体和综合的患者方法-,需要提供者和组织层面的干预措施来应对挑战并优化对多病患者的护理。
    Multimorbidity poses an immense burden on the healthcare systems globally, whereas the management strategies and guidelines for multimorbidity are poorly established. We aim to synthesize current evidence on interventions and management of multimorbidity.
    We searched four electronic databases (PubMed, Embase, Web of Science, and the Cochrane Database of Systematic Reviews). Systematic reviews (SRs) on interventions or management of multimorbidity were included and evaluated. The methodological quality of each SR was assessed by the AMSTAR-2 tool, and the quality of evidence on the effectiveness of interventions was assessed by the grading of recommendations assessment, development and evaluation (GRADE) system.
    A total of 30 SRs (464 unique underlying studies) were included, including 20 SRs of interventions and 10 SRs summarizing evidence on management of multimorbidity. Four categories of interventions were identified: patient-level interventions, provider-level interventions, organization-level interventions, and combined interventions (combining the aforementioned two or three- level components). The outcomes were categorized into six types: physical conditions/outcomes, mental conditions/outcomes, psychosocial outcomes/general health, healthcare utilization and costs, patients\' behaviors, and care process outcomes. Combined interventions (with patient-level and provider-level components) were more effective in promoting physical conditions/outcomes, while patient-level interventions were more effective in promoting mental conditions/outcomes and psychosocial outcomes/general health. As for healthcare utilization and care process outcomes, organization-level and combined interventions (with organization-level components) were more effective. The challenges in the management of multimorbidity at the patient, provider and organizational levels were also summarized.
    Combined interventions for multimorbidity at different levels would be favored to promote different types of health outcomes. Challenges exist in the management at the patient, provider, and organization levels. Therefore, a holistic and integrated approach of patient-, provider- and organization- level interventions is required to address the challenges and optimize care of patients with multimorbidity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:近年来,研究了胡萝卜和胡萝卜素在不同健康领域的益处。
    目的:本综述的目的是确定胡萝卜和胡萝卜素与多种健康结果之间的关联。
    方法:对胡萝卜和胡萝卜素的干预和观察研究以及任何健康结果的荟萃分析的证据进行综述。我们全面搜索了WebofScience,PubMed,和Embase。对于每个协会,我们使用随机效应和固定效应模型以及95%置信区间估计了总效应大小.
    结果:共检索了1329项研究,通过资格标准确定了30项具有26项健康结果的荟萃分析。胡萝卜的摄入与包括乳腺癌在内的多种癌症预后的较低风险相关。肺癌,胰腺癌,胃癌,尿路上皮癌和前列腺癌.摄入胡萝卜素与较低的骨折风险相关,年龄相关性白内障,晒伤,老年痴呆症,乳腺癌,肺癌,胰腺癌,胃癌,食道癌,前列腺癌和头颈癌(HNC)。血清胡萝卜素与全因死亡率呈负相关,乳腺癌和肺癌。
    结论:我们的研究表明,摄入胡萝卜或胡萝卜素可以降低各种健康结果的风险。本文受版权保护。保留所有权利。
    In recent years, the benefits of carrots and carotene in different areas of health have been examined. The purpose of this umbrella review was to identify the associations between carrots and carotene and multiple health outcomes. The review considered evidence from meta-analyses of interventional and observational studies of carrots and carotene and any health outcome. We comprehensively searched Web of Science, PubMed, and Embase. For each association, we estimated the summary effect size using random and fixed effects models and the 95% confidence interval. A total of 1329 studies were searched, and 30 meta-analyses with 26 health outcomes were identified that met the eligibility criteria. Carrot intake was associated with a lower risk of multiple cancer outcomes including breast cancer, lung cancer, pancreatic cancer, gastric cancer, urothelial cancer, and prostate cancer. Carotene intake was associated with a lower risk of fracture, age-related cataract, sunburn, Alzheimer\'s disease, breast cancer, lung cancer, pancreatic cancer, gastric cancer, esophageal cancer, prostate cancer, and head and neck cancer (HNC). Serum carotene was inversely associated with all-cause mortality, breast cancer, and lung cancer. Our study revealed that carrot or carotene intake could reduce the risk of various negative health outcomes. © 2023 Society of Chemical Industry.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号